/-- Announcement on Revising and Formulating Partial Management Systems
NEWS

-- Announcement on Revising and Formulating Partial Management Systems

Shanghai Stock Exchange
2025/08/27

Securities code: 603538 Securities abbreviation: Minova Announcement number: 2025-095

Convertible bond code: 113618 Convertible bond abbreviation: Miele Convertible Bond

Ningbo Menohua Pharmaceutical Co., Ltd.

Announcement on revising and formulating some of the company's management systems

The board of directors and all directors of the company guarantee that the contents of this announcement do not contain any false records or misleading statements.

or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its content.

Ningbo Menohua Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held on August 26, 2025

The 16th meeting of the fifth session of the Board of Directors reviewed and approved the "Regulations on Revising and Establishing Partial Management Systems of the Company"

Bill".

According to the "Company Law of the People's Republic of China", "Securities Law of the People's Republic of China" and "Articles of Association of Listed Companies"

"Introduction" and other relevant laws, regulations and normative documents, combined with the company's actual operation and management situation,

The board of directors agreed to revise and formulate some of the company's management systems. The specific situation is as follows:

Serial number Revised management system name

1 Rules of Procedure for Shareholders’ Meeting

2 Rules of Procedure for Board of Directors

  1. Working system of independent directors

4 Foreign investment management system

5 External guarantee management system

6 Related party transaction management system

7 Raised funds management system

8 Implementation Rules of Cumulative Voting System

9 Code of Conduct for Controlling Shareholders and Actual Controllers

10 Code of Conduct for Directors and Senior Management

11 Rules of Procedure of the Audit Committee of the Board of Directors

12 Rules of Procedure of the Nomination Committee of the Board of Directors

13 Rules of Procedure of the Remuneration and Appraisal Committee of the Board of Directors

14 Rules of Procedure of the Strategy Committee of the Board of Directors

15 General Manager Work Rules

16 Working Rules for the Secretary of the Board of Directors

17 Information disclosure management system

18 Information disclosure exemption and suspension management system

19 Insider information insider registration and management system

20 Investor Relations Management System

21 Management Measures for Holding Subsidiaries

22 Internal audit system

23 Accounting firm selection and recruitment system

24 Measures for separate counting and disclosure of votes of small and medium-sized investors at shareholders’ meetings

25 Internal control system for financial derivatives trading business

26 Foreign exchange derivatives trading business management system

Serial number Name of the established management system

27 Special meeting system for independent directors

28 Remuneration management system for directors and senior managers

29 Resignation management system for directors and senior managers

30 Management system for company shares held by directors and senior managers and their changes

31 Code of conduct for directors, senior managers and other relevant entities in releasing information to the outside world 32 Accountability system for major errors in annual report information disclosure

33 Public opinion management system

34 Reception and promotion work and information disclosure registration system

For details, please refer to the company’s designated information disclosure on the Shanghai Stock Exchange website (www.sse.com.cn) and other

The company’s relevant management systems disclosed by the media on the same day.

The revision and formulation of the above-mentioned management system have been reviewed and approved at the 16th meeting of the fifth session of the board of directors of the company.

Among them, items 1-10 and 28 still need to be submitted to the company’s shareholders’ meeting for review. The remaining systems have been implemented since the fifth session of the Board of Directors.

It will come into effect on the date of review and approval at the 16th meeting of the Council.

The full text of the revised above-mentioned management system can be found on the website of Shanghai Stock Exchange (www.sse.com.cn).

Announcement is hereby made.

Board of Directors of Ningbo Menohua Pharmaceutical Co., Ltd.

August 27, 2025